Skip to main content

Table 1 Clinical characteristics of patients with Dry Synovitis

From: Dry synovitis, a rare entity distinct from juvenile idiopathic arthritis

Sex

Age at onset

(years)

Age at diagnosis

(years)

Year of diagnosis

No. joints involved at diagnosis

CRP (mg/l)

ESR (mm/h)

Treatment

Clinical and Imaging findings

Imaging at diagnosis

Clinical course

Follow-up imaging

F

8

9

2007

18

0,0

12

NSAIDs, CS, MTX, anti-TNF

No synovial thickening, synovial enhancement, joint effusion or joint space narrowing

Good clinical response on anti-TNF treatment, although need for bilateral hip replacement

Progressive destruction of hip joints with joint effusion, joint space narrowing, bone edema and bone erosions

F

3

14

2009

30

0,0

8

NSAIDs, CS, MTX, anti-TNF

Diffuse and moderate synovitis on wrists. Bone edema and geodes with discrete joint effusion on hips. Joint space narrowing and erosions on wrists and hips

Persistent, manifest limitation in mobility in multiple joints and need of bilateral hip replacement

Progressive destruction of hip joints with very moderate persistent joint effusion

F

4

10,4

2012

31

0,6

8

NSAIDs, CS, MTX

Discrete hips joint effusion and osteochondral involvement with joint space narrowing and erosions

Persistent reduced mobility in the hip

Progressive destruction of hip joints. Development of diffuse and moderate articular and peritendinous synovitis on wrists

F

8

9,1

2014

71

5,3

2

NSAIDs, CS, MTX

Diffuse and moderate articular and peritendinous synovitis with no joint effusion

Persistent limitation in mobility of wrists, ankles and elbow

No follow-up imaging available after start of treatment

M

1,2

4,9

2013

71

1,4

12

NSAIDs, CS, MTX

Diffuse and moderate articular and peritendinous synovitis with no joint effusion or osteochondral damage

Clinically good response on treatment with persistence of only mild extension deficit in 1 wrist, some PIP joints and the neck

Persistent diffuse and moderate articular and peritendinous synovitis with no destructive damage on cartilage and bone

M

16

18,6

2014

26

3,5

7

NSAIDs, CS, MTX, anti-TNF

Diffuse and moderate peritendinous synovitis with osteochondral damage (bone edema and geodes) and no joint effusion.

Persistent reduced mobility in wrists, MCP joints, hip and ankles

No follow-up imaging available after start of treatment

F

7

8

2016

71

12,0

15

NSAIDs, CS, MTX, anti-TNF

Diffuse and moderate to intense articular and peritendinous synovitis with very limited bone edema and no joint effusion

Slowly improvement with persistence of mild limitation in mobility of both wrists, PIP 3&4 and MCP 1 & 2 of both hands

No follow-up imaging available after start of treatment

F

8

9,7

2017

71

4,1

12

NSAIDs, CS, MTX

Diffuse and moderate to intense articular and peritendinous synovitis with very limited bone edema and no joint effusion

Persistent limitation in the left wrist and ankle

No follow-up imaging available after start of treatment

F

2,4

2,9

2012

8

1,6

67

NSAIDs, CS, MTX

Diffuse and moderate articular synovitis

Clinical remission off treatment. Residual joint contractures at multiple joints and osteoporosis

No follow-up imaging available after start of treatment

F

5,9

6

2011

22

0,2

6

NSAIDs, CS, MTX

Diffuse and moderate articular and peritendinous synovitis

with limited osteochondral damage (bone edema and geodes) and no joint effusion

Persistent reduced mobility of wrists, MCP and PIP joints

Absence of inflammatory signs on MRI

M

3,1

5,8

2011

22

0,3

8

NSAIDs, CS, MTX, anti-TNF

Diffuse and moderate articular and peritendinous synovitis

with limited bone edema and no joint effusion

Reduced range of motion at wrists, MCP and PIP joints

Osteopenia, joint space narrowing on X-ray

M

4,9

10,2

2012

37

0.3

2

NSAIDs, CS, MTX

Diffuse and moderate articular and peritendinous synovitis

Reduced range of motion at both elbows and wrists

Joint space narrowing but no erosions on X-ray